dc.contributor.authorYorulmaz, Saziye
dc.contributor.authorTabaei, Seyed R.
dc.contributor.authorKim, Myunghee
dc.contributor.authorSeo, Jeongeun
dc.contributor.authorHunziker, Walter
dc.contributor.authorSzebeni, János
dc.contributor.authorCho, Nam-Joon
dc.identifier.citationYorulmaz, S., Tabaei, S. R., Kim, M., Seo, J., Hunziker, W., Szebeni, J., et al. (2015). Membrane attack complex formation on a supported lipid bilayer: initial steps towards a CARPA predictor nanodevice. European Journal of Nanomedicine, 7(3), 245-255.en_US
dc.description.abstractThe rapid advance of nanomedicines and biologicals in pharmacotherapy gives increasing importance to a common adverse effect of these modern therapeutics: complement (C) activation-related pseudoallergy (CARPA). CARPA is a relatively frequent and potentially lethal acute immune toxicity of many intravenous drugs that contain nanoparticles or proteins, whose prediction by laboratory or in vivo testing has not yet been solved. Preliminary studies suggest that proneness of the drug to cause C activation in the blood of patients may predict the individual risk of CARPA, thus, a sensitive and rapid bedside assay for individualized assessment of a drug’s C activating potential could alleviate the CARPA problem. The goal of the present study was to lay down the foundations of a novel approach for real-time sensing of C activation on a supported lipid bilayer platform. We utilized the quartz crystal microbalance with dissipation (QCM-D) monitoring technique to measure the self-assembly of C terminal complex (or membrane attack complex [MAC]) on supported lipid bilayers rapidly assembled by the solvent-assisted lipid bilayer (SALB) formation method, as an immediate measure of C activation. By measuring the changes in frequency and energy dissipation of deposited protein, the technique allows extremely sensitive real-time quantification of the sequential assembly of MAC from its molecular components (C5b-6, C7, C8 and C9) and hence, measure C activation in the ambient medium. The present paper delineates the technique and our initial evidence with purified C proteins that the approach enables sensitive and rapid (real-time) quantification of MAC formation on a silicon-supported planar (phospho) lipid bilayer, which can be used as an endpoint in a clinically useful bedside C activation assay.en_US
dc.description.sponsorshipNRF (Natl Research Foundation, S’pore)en_US
dc.format.extent11 p.en_US
dc.relation.ispartofseriesEuropean Journal of Nanomedicineen_US
dc.rights© 2015 European Journal of Nanomedicine (EJNM). This paper was published in European Journal of Nanomedicine and is made available as an electronic reprint (preprint) with permission of European Journal of Nanomedicine (EJNM). The published version is available at: [http://dx.doi.org/10.1515/ejnm-2015-0016]. One print or electronic copy may be made for personal use only. Systematic or multiple reproduction, distribution to multiple locations via electronic or other means, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper is prohibited and is subject to penalties under law.en_US
dc.subjectBedside diagnosisen_US
dc.subjectHypersensitivity reactions
dc.subjectImmune toxicity
dc.subjectSolvent-assisted lipid bilayer (SALB) formation method
dc.subjectSupport lipid bilayer
dc.titleMembrane attack complex formation on a supported lipid bilayer: initial steps towards a CARPA predictor nanodeviceen_US
dc.typeJournal Article
dc.contributor.schoolSchool of Materials Science and Engineeringen_US
dc.description.versionPublished versionen_US

Files in this item


This item appears in the following Collection(s)

Show simple item record